Obesity: a new risk factor for cardiac syndrome X?
نویسندگان
چکیده
منابع مشابه
Metabolic Syndrome as a Risk Factor for Osteoarthritis
Metabolic syndrome refers to a set of conditions that include high blood pressure, increased insulin level in the blood, the accumulation of the excess fat around the abdomen, and increased blood lipids. In metabolic syndrome, the vast majority of these conditions are simultaneously present, and the risk of developing heart disease, stroke, and diabetes rises. Besides, osteoarthritis or degen...
متن کاملMaternal obesity - a risk factor for metabolic syndrome in children
OBJECTIVE To determine the association between the metabolic syndrome in children (MS) and the pre-pregnancy nutritional status of the mother. DESIGN AND METHODS A total number of 180 children aged between 6-19 years were examined. Self reported data about parents and their children were collected. The children underwent physical examination; weight, height, waist circumference, blood pressur...
متن کاملIs obesity a new risk factor for gastritis?
Obesity has become a major concern among gastroenterologists due to its large influence on gastrointestinal and hepatic diseases: reflux esophagitis, pancreatitis, gallstone disease, liver fibrosis, and neoplastic tumors of the esophagus, pancreas, and colon. Studies of morbid obese subjects undergoing bariatric surgery have revealed that obesity is related with an increased prevalence of endos...
متن کاملIs fragile X syndrome a risk factor for dizygotic twinning?
Several researchers have looked for an association between fragile X (FRAXA) syndrome and dizygotic (DZ) twinning. Fryns [1986] reported a 4-fold increase in twinning in a study of 134 obligate FRAXA carriers, while Turner et al. [1994] noted a twinning rate of one in 11 in 253 carriers of the FRAXA premutation. On the other hand, Sherman et al. [1988] found no excess of twins in fragile X pedi...
متن کاملMetoprolol improves endothelial function in patients with cardiac syndrome X
Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta blocker, on endothelial function in CSX patients. The study included 25 CSX patients (20 female/ 5 ma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cardiovascular Drugs and Therapy
سال: 2012
ISSN: 0920-3206,1573-7241
DOI: 10.1007/s10557-012-6390-4